Virginia Retirement Systems Et Al Mersana Therapeutics, Inc. Transaction History

Virginia Retirement Systems Et Al

  • $10.1 Billion
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 30, 2021
SELL
$15.31 - $26.52 $231,181 - $400,452
-15,100 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$16.84 - $27.59 $74,096 - $121,396
-4,400 Reduced 22.56%
15,100 $402,000
Q3 2020

Nov 12, 2020
SELL
$16.2 - $25.7 $32,400 - $51,400
-2,000 Reduced 9.3%
19,500 $363,000
Q2 2020

Aug 12, 2020
BUY
$5.24 - $23.4 $112,660 - $503,099
21,500 New
21,500 $503,000

Others Institutions Holding MRSN

# of Institutions
136
Shares Held
101M
Call Options Held
77.2K
Put Options Held
453K
View Full List

About Mersana Therapeutics, Inc.

MRSN Quotes by TradingView
  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $45.7M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Virginia Retirement Systems Et Al Portfolio

Follow Virginia Retirement Systems Et Al and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email